Rhumatologie. Anti-TNF alpha: quels risques infectieux? Recommandations pratiques [Rheumatology. TNF alpha-inhibitors: infection risks? Practical recommendations].
Détails
ID Serval
serval:BIB_D6470C11F20E
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Rhumatologie. Anti-TNF alpha: quels risques infectieux? Recommandations pratiques [Rheumatology. TNF alpha-inhibitors: infection risks? Practical recommendations].
Périodique
Revue Médicale Suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
2011
Volume
7
Numéro
277
Pages
75-6, 78-9
Langue
français
Notes
Publication types: English Abstract ; Journal Article ; Review
Résumé
Anti-TNF alpha are immunomodulatory treatments prescribed for some rheumatologic inflammatory diseases (ex: spondylarthropathy, rheumatoid polyarthritis). The randomised studies suggested that anti-TNF alpha therapy is associated with an overall risk of infectious diseases. The results of the observational studies are more reassuring. In this article, we will describe some results of theses studies and propose some practical recommendations in use of the anti-TNF alpha therapy.
Mots-clé
Antirheumatic Agents/adverse effects, Bacterial Infections/etiology, Bacterial Infections/prevention & control, Humans, Opportunistic Infections/etiology, Opportunistic Infections/prevention & control, Rheumatic Diseases/drug therapy, Tumor Necrosis Factor-alpha/antagonists & inhibitors
Pubmed
Création de la notice
16/02/2012 14:40
Dernière modification de la notice
20/08/2019 15:56
Données d'usage
